Achyut Healthcare Ltd vs Jagsonpal Pharmaceuticals Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 05, 2026

Key Highlights

The Latest Trading Price of Achyut Healthcare Ltd is ₹ 5.26 as of 05 May 15:30 . The P/E Ratio of Achyut Healthcare Ltd changed from 342.5 on March 2022 to 163 on March 2025 . This represents a CAGR of -16.94% over 4 yearsThe P/E Ratio of Jagsonpal Pharmaceuticals Ltd changed from 12.2 on March 2021 to 25.9 on March 2025 . This represents a CAGR of 16.25% over 5 years The Market Cap of Achyut Healthcare Ltd changed from ₹ 13.85 crore on March 2022 to ₹ 76.79 crore on March 2025 . This represents a CAGR of 53.45% over 4 yearsThe Market Cap of Jagsonpal Pharmaceuticals Ltd changed from ₹ 208.41 crore on March 2021 to ₹ 1433 crore on March 2025 . This represents a CAGR of 47.06% over 5 years The revenue of Achyut Healthcare Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 revenue of ₹ 1.61 crore. This represent the decline of -100% The revenue of Jagsonpal Pharmaceuticals Ltd for the Mar '26 is ₹ 67.37 crore as compare to the Dec '25 revenue of ₹ 75.92 crore. This represent the decline of -11.26% The ebitda of Achyut Healthcare Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 ebitda of ₹ 0.04 crore. This represent the decline of -100% The ebitda of Jagsonpal Pharmaceuticals Ltd for the Mar '26 is ₹ 14.33 crore as compare to the Dec '25 ebitda of ₹ 17.16 crore. This represent the decline of -16.49% The net profit of Achyut Healthcare Ltd changed from ₹ 0.03 crore to ₹ 0 crore over 6 quarters. This represents a CAGR of -100.00% The net profit of Jagsonpal Pharmaceuticals Ltd changed from ₹ 5.33 crore to ₹ 8.76 crore over 8 quarters. This represents a CAGR of 28.20% The Dividend Payout of Achyut Healthcare Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Jagsonpal Pharmaceuticals Ltd changed from 15.36 % on March 2021 to 29.99 % on March 2025 . This represents a CAGR of 14.32% over 5 years .

About Achyut Healthcare Ltd

Achyut Healthcare Limited was incorporated as Achyut Securities Private Limited' on January 11, 1996 as a Private Limited Company under the Companies Act, 1956 with the Registrar of Companies, Gujarat, Dadra and Nagar Haveli.
The Company name was changed to Achyut Healthcare Private Limited', and a fresh Certificate of Incorporation dated November 26, 2002.
Subsequently, the Company got converted from a Private Limited to Public Limited and the name of the Company changed to Achyut Healthcare Limited', and a fresh Certificate of Incorporation dated November 30, 2021 was issued to the Company by Registrar of Companies, Gujarat at Ahmedabad. The Company is engaged in trading of Cenzure, Arpimune, Azathioprine IP, Everolimus, Mycophenolate Mofetil USP, Mycophenolate Sodium USP, Sirolimus, Tacrolimus USP, Infrared thermometer, Ascorbic Acid Coated Vitamin C, Calcium carbonate oyster, Cellulose acetate Phthalate, Chlorthalidone IP, Croscarmellose Sodium IP/USP, DIBasic Calcium Phosphate IP, DIEthyl Phthalate, Diltiazem Hydrochloride IP, Easy Coat Fc Titanium Dioxide, Escitalopram IP, Escitalopram Oxalate, Favipiravir among many other products.

About Jagsonpal Pharmaceuticals Ltd

Promoted by Rajpal Singh Kochhar in August, 1978, Jagsonpal Pharmaceuticals Limited is engaged in the manufacture and marketing bulk drugs and pharmaceuticals at its plant at Faridabad in Haryana.
The Company has adopted the strategy of clubbing all its products in seven groups for effective marketing and reducing costs.
Simultaneously, it has geared up to set up an ultra modern multi-purpose basic drugs and formulation plant through its subsidiary, Jagsonpal Exports India Pvt Ltd. The company has a strategic alliance with Fidia Spa, Italy; and B Spofola, Czechoslovakia; to manufacture sophisticated drugs in India.
It has tied up with another Israel-based company, Makhteshim Chemical Works, for acquiring the marketing rights of an anti-oxidant product.
In 1994, the company has also promoted Aresco Financial Services, a new financial company.

FAQs for the comparison of Achyut Healthcare Ltd and Jagsonpal Pharmaceuticals Ltd

Which company has a larger market capitalization, Achyut Healthcare Ltd or Jagsonpal Pharmaceuticals Ltd?

Market cap of Achyut Healthcare Ltd is 123 Cr while Market cap of Jagsonpal Pharmaceuticals Ltd is 1,388 Cr

What are the key factors driving the stock performance of Achyut Healthcare Ltd and Jagsonpal Pharmaceuticals Ltd?

The stock performance of Achyut Healthcare Ltd and Jagsonpal Pharmaceuticals Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Achyut Healthcare Ltd and Jagsonpal Pharmaceuticals Ltd?

As of May 5, 2026, the Achyut Healthcare Ltd stock price is INR ₹5.26. On the other hand, Jagsonpal Pharmaceuticals Ltd stock price is INR ₹206.8.

How do dividend payouts of Achyut Healthcare Ltd and Jagsonpal Pharmaceuticals Ltd compare?

To compare the dividend payouts of Achyut Healthcare Ltd and Jagsonpal Pharmaceuticals Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.